DNA Methylation and Repair

Early work linking DNA modification to gene activity

Holliday and Pugh's 1975 journal article in Science, titled 'DNA modification mechanisms and gene activity during development', is an early publication that names chemical modification of DNA and gene activity together. The PubMed record for it has no abstract, and its index terms include methylation and enzyme repression, so this page relies on the title and index terms and does not describe the paper's findings in detail.

A later review by Moore, Le and Fan, published in 2013, describes DNA methylation as a process that changes across development. In the review's account, the methylation pattern across the genome changes through a dynamic process that includes both de novo methylation and demethylation, and postmitotic neurons still express the enzymes involved.

Folate and the methyl group supply

Crider and colleagues' 2012 review in Advances in Nutrition describes folate as a key source of the one-carbon group used to methylate DNA. The review states that DNA methylation is critical to normal genome function and that aberrant patterns are present in cancer, imprinting disorders and developmental disabilities. The link between folate and methylation is therefore an established research question, separate from the consumer claims discussed later on this page.

Repair as a separate research field

DNA repair is studied as its own field, and its mechanisms are described in reviews such as Chatterjee and Walker's 2017 summary in Environmental and Molecular Mutagenesis. The sources reviewed for this page do not supply a dated history of how repair research developed, so this page does not give one. Dates in this section are limited to the publications cited.

DNA methylation

Moore and colleagues describe DNA methylation as the addition of a methyl group to the cytosine base, mostly at CpG sites. Methylation can silence genes in two main ways. The methyl mark can block transcription factors from binding DNA, and it can be recognized by methyl-binding proteins, including the MBD, UHRF and zinc-finger families, which recruit repressive complexes. These complexes often include enzymes that modify histones and compact chromatin.

The term is used in narrow and broad senses. In research, it refers to a measured chemical state at defined sites or across the genome. In wellness material, it is often used as a general word for gene health or for a state that can be supported. The first sense is a laboratory measurement. The second is not defined in the sources reviewed.

DNA repair and repair capacity

Chatterjee and Walker list five main repair routes. Base excision repair removes small, non-helix-distorting base damage, starting with a DNA glycosylase. Nucleotide excision repair removes bulky, helix-distorting lesions such as ultraviolet dimers. Mismatch repair corrects replication errors. Homologous recombination repairs double-strand breaks without error, using a template, and non-homologous end joining rejoins broken ends directly.

Studies of diet often measure repair capacity, meaning how well a sample of cells repairs a lesion in a laboratory assay. This is a different measure from repair of damage in a living person. The folate and kiwifruit studies cited later use this kind of assay.

Related and confusable terms

An epigenetic clock is a score built from methylation at many sites to estimate biological age. It is a different measure from methylation at a single site, and the reviewers cited here treat the meaning of clock changes as debated. A methyl donor is a molecule, such as folate, that supplies methyl groups, and a donor does not by itself show that methylation has changed.

Methylation as a trial outcome

In nutrition and lifestyle research, methylation is used as an outcome measure, most often as an epigenetic clock. Fitzgerald and colleagues measured methylation in saliva and used the Horvath clock. Yaskolka Meir and colleagues used the Illumina EPIC array and several clocks, and Kou and colleagues used DunedinPACE and related measures.

Trials in this area usually combine several elements, such as diet, exercise, sleep or supplements, so an observed change cannot be assigned to one element without a design that separates them. The Fitzgerald program combined diet, sleep, exercise and relaxation guidance with supplemental probiotics and phytonutrients over eight weeks.

How wellness material frames the terms

Wellness and alternative-health material describes diet, supplements and lifestyle programs as ways to support methylation, slow biological aging or protect DNA from damage. Practitioners in these settings are described as framing methyl-donor nutrients as methylation support. The forms of this framing that the sources here address are a folate or methyl-donor nutrient that supports methylation, a diet that changes epigenetic age, and a food that improves repair capacity.

The sources reviewed do not document how these claims are distributed, so this section does not estimate how common they are. It describes the claim types and the studies that test the underlying measures.

Slowing biological aging

Claims that diet or lifestyle slows biological aging are tested with epigenetic clocks. In the Fitzgerald pilot trial, the program group had a 3.23-year lower DNAmAge than controls at the end of the program, with a p value of 0.018. The within-group decrease of 1.96 years had a p value of 0.066, which the authors describe as a strong trend. The authors call for larger and longer trials.

A 2024 systematic review found that two of four dietary-pattern studies linked healthy diets to lower epigenetic age acceleration, and one found no significant effect on epigenetic age. The review's authors describe this as preliminary.

Supporting methylation and folate status

Crider and colleagues state that low folate status is associated with decreases in global DNA methylation, and that evidence on specific genomic regions is limited. The review states there is no direct evidence that high dietary folate or folic acid intake leads to aberrant methylation, changes in gene expression or disease. A claim that a folate product supports methylation therefore rests mainly on a link between deficiency and lower methylation.

In a trial in 61 healthy volunteers, folic acid at 1.2 mg a day for 12 weeks reduced uracil misincorporation in lymphocyte DNA, a marker of folate status. Global DNA methylation and DNA strand breakage did not change.

Repairing DNA damage

The kiwifruit crossover study by Collins and colleagues reported lower endogenous oxidation of bases in lymphocyte DNA and higher ex vivo repair of an oxidized base during kiwifruit periods. The authors also wrote that the effect would probably decrease cancer risk. That statement is their inference and was not measured with a clinical endpoint in the abstract. None of the sources reviewed shows that a diet, supplement or practice repairs DNA damage in a person.

Systematic review of nutrition trials

García-García and colleagues' 2024 systematic review in Frontiers in Aging included 21 clinical studies, 13 randomized and 7 non-randomized, of nutrition strategies and methylation or epigenetic clocks. Most studies were in Europe, North America or Australia. The review excluded children, prenatal studies and people with most medical conditions.

For dietary patterns, four studies reported mixed results. Two linked healthy diets to lower epigenetic age acceleration, one reported small increases in LINE-1 methylation, and one found no significant effect on epigenetic age. For folic acid, results conflicted across the studies reviewed. For polyunsaturated fatty acids, omega-3 supplementation and an olive oil comparator did not change global methylation in some trials. The authors conclude that evidence is scarce and that larger randomized trials are needed.

Trials of diet and lifestyle programs

The Fitzgerald trial is a pilot with 43 healthy men aged 50 to 72 and an untreated control group, and its abstract reports results on saliva methylation. Several authors list affiliations with an integrative-medicine institute and a nutrition association, and one lists a commercial epigenetics company. These affiliations do not establish bias, but they are relevant to how the results are read.

The DIRECT PLUS trial randomized 256 adults with abdominal obesity or dyslipidemia to three diets. The methylation clocks did not differ in change between diets overall. Within the trial, greater adherence to the green-Mediterranean diet was associated with a larger reduction in two clocks, and intake of green tea and Mankai was linked to a change in one clock. These are associations within a trial that used several clocks, not a direct comparison of the foods.

The MACRO trial analysis of 144 adults with obesity found that changes in epigenetic aging measures were not associated with changes in cardiometabolic biomarkers, and did not mediate the effects of weight loss. The authors caution against treating epigenetic aging as a modifiable intervention target in short-term studies.

Folate and repair markers

The Basten study measured folate-related and DNA stability markers in healthy volunteers. Increasing folate status reduced uracil misincorporation, but it also decreased base excision repair capacity in the volunteers with the lowest starting folate status. A repair marker therefore fell in one subgroup, and the study does not support a general claim that folate improves DNA repair.

Where the evidence is missing

The sources reviewed do not include a randomized trial that measured repair of DNA damage in people with a clinical endpoint. Methylation outcomes are mostly surrogate measures, such as epigenetic clocks and global methylation, and their link to health outcomes is debated. Studies that measure repair capacity use laboratory assays on cells, and the sources reviewed do not test those assays against disease outcomes.

High folic acid intake

The NIH Office of Dietary Supplements states that large amounts of folate can correct the anemia of vitamin B12 deficiency but not the neurological damage it can cause. It notes concern that high folic acid intake might mask B12 deficiency until neurological effects become irreversible, while stating that questions remain. The fact sheet gives 1,000 micrograms a day as the tolerable upper intake level for adults and notes that about 5 percent of men and women aged 51 to 70, and men aged 71 and older, exceed it, mostly from supplements.

People who take a folate or B vitamin product alongside medicines, who have a diagnosed condition, or who are pregnant should discuss the product with a clinician before starting or changing it. The fact sheet itself states that its information should not take the place of medical advice.

Unverified genetic methylation tests

The American College of Medical Genetics and Genomics guideline by Hickey and colleagues states that MTHFR polymorphism testing is frequently ordered in thrombophilia evaluation, and that the hypothesized links to disease were not supported by recent meta-analyses. The guideline concludes that testing has minimal clinical utility and should not be part of routine thrombophilia evaluation.

This guideline addresses clinical ordering by physicians. It does not address direct-to-consumer tests or other methylation markers, and the sources reviewed here do not report harms from such tests. Any result from a consumer test should be interpreted with a clinician, because the sources reviewed do not establish what such a result would mean for an individual's care.

Harms, care boundaries and what is not reported

The diet and lifestyle trials cited here report benefits only as changes in methylation measures, and the abstracts reviewed do not describe adverse events. That absence does not show that no harm occurred, and the trials were small and short. Kou and colleagues caution against treating epigenetic aging as a target in short-term studies, and the systematic review's authors describe the evidence as preliminary.

This page is information only. It does not diagnose, recommend a product, or replace the care a clinician provides. People with symptoms, a diagnosed condition or a medicine regimen should seek medical advice before changing diet or supplements for these reasons.